NYSE:ELVHealthcare
Will Elevance’s 2026 Guidance and MA Update Reshape Elevance Health's (ELV) Investment Narrative?
Earlier this week, Elevance Health reaffirmed its 2026 earnings and benefit expense guidance and presented at Goldman Sachs’ 47th Annual Global Healthcare Conference in Miami, underlining its outlook for adjusted earnings of at least $26.75 per diluted share and a targeted benefit expense ratio near 90.2%.
Investor attention has also been reinforced by a higher-than-anticipated Medicare Advantage payment update and Elevance Health’s inclusion among value investor Seth Klarman’s top stock...